SCHEMBL4895877

SCHEMBL4895877

CCC(OC(N)=O)c1nc(C2CC2)c(Sc2cc(C#N)cc(C#N)c2)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903068 0.87 CXCR2 (0.31)
SCHEMBL4902465 0.84 KCNH2 (0.33)
SCHEMBL4896688 0.83
SCHEMBL4900372 0.83 PDE2A (0.32)
SCHEMBL4902690 0.82 ALDH1A1 (0.33)
SCHEMBL4875986 0.79 KCNH2 (0.36)
SCHEMBL4877771 0.76 ALDH1A1 (0.31)
SCHEMBL4892355 0.72 PKM (0.34)
SCHEMBL4900356 0.72 FASN (0.32)
SCHEMBL4903195 0.70 FASN (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132549-A1 Sulphur-Linked Imidazone Compounds for the Treatment of Hiv/Aids PFIZER INC. (US) 2008-06-05 US claimed
US-20080132549-A1 Sulphur-Linked Imidazone Compounds for the Treatment of Hiv/Aids PFIZER INC. (US) 2008-06-05 US disclosed
EP-1740550-A1 SULPHUR-LINKED IMIDAZOLE COMPOUNDS FOR THE TREAMENT OF HIV Pfizer Limited (GB) 2007-01-10 EP disclosed
WO-2005100322-A1 SULPHUR-LINKED IMIDAZOLE COMPOUNDS FOR THE TREAMENT OF HIV PFIZER LIMITED (GB) 2005-10-27 WO disclosed